Announced Wed, 15 Jul · 17:04 IST
Reg 74(5) certificate filed for Q1FY27, no rematerialisation requests
Compliance View source PDF
VAISHALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹7.85
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-0.1+0.5+0.9+0.6+1.3-1.4————
Up moveDown movePending
AI summary
Vaishali Pharma has submitted the Regulation 74(5) certificate to NSE for April to June 2026 quarter. Bigshare Services, the company's Registrar and Share Transfer Agent, confirmed that no shareholder requested rematerialisation of shares during the quarter. This is a standard quarterly compliance filing required by SEBI depository rules.
Likely market impact
No impact on shareholders. Routine procedural compliance filing with no operational or financial effect on the company.